Translated complex Phase III clinical trial data from top-tier medical literature (The New Englan...Translated complex Phase III clinical trial data from top-tier medical literature (The New Englan...
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started
Translated complex Phase III clinical trial data from top-tier medical literature (The New England Journal of Medicine) and US FDA Prescribing Information into an engaging, accessible Plain Language Summary (PLS) designed for patients, patient advocacy groups, and non-specialist audiences.
The summary clearly communicates complex study endpoints, such as 3-point MACE reductions, cardiovascular mortality statistics, and safety considerations, using health-literacy best practices while maintaining 100% scientific accuracy and compliance with source data.
Post image
Post image
Post image
Post image
Back to feed
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started